Competing risks analysis of recurrent venous thromboembolism ( VTE) and bleeding on anticoagulation in patients with cancer-associated VTE

被引：0
|
作者：
Simon, David [1 ]
Le Mao, Raphael [2 ]
Raj, Leela [3 ]
Espinasse, Benjamin [2 ]
De Moreuil, Claire [2 ]
Tromeur, Cecile [2 ]
Guegan, Marie [1 ]
Poulhazan, Elise [1 ]
Le Moigne, Emmanuelle [2 ]
Lacut, Karine [2 ]
Leroyer, Christophe [2 ]
Mahe, Isabelle [4 ,5 ]
Nowak, Emmanuel [1 ]
Couturaud, Francis [2 ]
机构：
[1] Univ Brest, FCRIN INNOVTE, CHU Brest, CIC1412 INSERM,INSERM U1304GETBO, Brest, France
[2] Univ Brest, FCRIN INNOVTE, CHU Brest, Dept Med Interne & Pneumol,INSERM U1304 GETBO, Brest, France
[3] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[4] Hop Louis Mourier, AP HP, Serv Med Interne, F-92700 Colombes, France
[5] Univ Paris Cite, INSERM UMR S1140 7, F-75006 Paris, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2245
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Venous thromboembolism (VTE) as first sign of occult malignancy is associated with increased risk of recurrent VTE
    Braekkan, S.
    Johansen, E. M.
    Mathiesen, E. B.
    Njolstad, I.
    Wilsgaard, T.
    Stormer, J.
    Hansen, J. -B.
    THROMBOSIS RESEARCH, 2007, 120 : S176 - S176
  • [22] Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes
    Shaw, Joseph R.
    Douketis, James
    Le Gal, Gregoire
    Carrier, Marc
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (07) : 1171 - 1178
  • [23] Tissue factor (TF) as predictor of recurrent venous thromboembolism (VTE): risk factor and biomarker analysis from the catch trial of treatment of cancer-associated VTE with tinzaparin or warfarin
    Khorana, A. A.
    Kamphuisen, P. W.
    Meyer, G.
    Bauersachs, R.
    Janas, M. S.
    Jarner, M. F.
    Lee, A. Y. Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 29 - 29
  • [24] TARGETED THERAPIES (TT) AND INDIVIDUAL RISK FACTORS FOR CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM (VTE)
    Soini, B.
    Caffo, O.
    Caldara, A.
    Ferro, A.
    Murgia, V
    Valduga, F.
    Eccher, C.
    Galligioni, E.
    ANNALS OF ONCOLOGY, 2009, 20
  • [25] Predicting the risk of recurrent venous thromboembolism (VTE)
    Michael B. Streiff
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 353 - 366
  • [26] Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?
    Xu, Ke
    Chan, Noel C. C.
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) : 487 - 489
  • [27] Trends of cancer-associated venous thromboembolism (VTE) in the United States (2005-2014)
    Almohammed, Omar A.
    Lai, Leanne
    Khanfar, Nile M.
    Bleidt, Barry
    Aljadhey, Hisham
    THROMBOSIS RESEARCH, 2019, 182 : 110 - 115
  • [28] Incidence of Cancer-Associated Venous Thromboembolism (VTE): A Population-Based Cohort Study
    Ashrani, Aneel A.
    Heit, John A.
    Crusan, Daniel J.
    Petterson, Tanya M.
    Bailey, Kent R.
    Melton, L. Joseph, III
    BLOOD, 2008, 112 (11) : 1306 - 1306
  • [29] Cancer-associated venous thromboembolism: the Onco-VTE START2-Registry
    Antonucci, E.
    Barcella, L.
    Russo, L.
    Chistolini, A.
    Serrao, A.
    Elmi, G.
    Sivera, P.
    Falanga, A.
    Palareti, G.
    THROMBOSIS RESEARCH, 2022, 213 : S39 - S39
  • [30] Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score
    Pfaundler, Nubio
    Limacher, Andreas
    Stalder, Odile
    Mean, Marie
    Rodondi, Nicolas
    Baumgartner, Christine
    Aujesky, Drahomir
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (05) : 1154 - 1161
12345